EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?

Patrick Hilley iD, Darren Wong iD, Peter De Cruz iD

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izae196 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Patrick Hilley und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Austin Hospital, Melbourne, Australia. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Pharmacists, Professional Role, Patient Care Team. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: NHMRC Emerging Leader 2 Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization has recommended that the management of chronic diseases such as inflammatory bowel disease (IBD) should be undertaken using an integrated approach delivered by a multidisciplinary team. Although the composition of an IBD multidisciplinary team has been well described, the inclusion of an IBD pharmacist as a core member has been more recent, with variable uptake within IBD services internationally. While pharmacists continue to play the traditional role of safe prescribing and monitoring of immunosuppressive therapies, their role within the IBD team is rapidly expanding; however, the value, in terms of both clinical outcomes as well as financial savings (where available), which they add to IBD services has been less well described. In this narrative review, we perform a comprehensive evaluation of the literature detailing the expanding roles that IBD pharmacists play and describe opportunities that exist for integrated pharmacists to add value to IBD service delivery. Medication and adherence counseling, immunosuppressive monitoring, uptake of biosimilars, therapeutic drug monitoring, health promotion and prevention appear to be key areas where integrated pharmacists can add the most value to IBD patients and services. In particular, integrated IBD pharmacists can improve patient outcomes via rigorous monitoring pre and post initiation of drug therapies; focused medication counseling; advice on improving adherence; implementation of novel approaches to medication usage, and; strategies to help sustain IBD service delivery. These data can be used to further build a case for those seeking to add pharmacists to their team/services. Future studies should focus on evaluating the impact of an integrated IBD pharmacist on quality-of-care delivery together with the clinical and financial value added to IBD services compared to services that lack an integrated IBD pharmacist role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesPharmacistsProfessional RolePatient Care TeamDelivery of Health Care, IntegratedHumansImmunosuppressive AgentsDisease Management

Stichwörter der Autor:innen

inflammatory bowel diseasemedication optimizationmonitoringpharmacistsafety

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, The Austin Hospital, Melbourne, Australia.
  • Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, Australia.
  • Department of Pharmacy, The Austin Hospital, Melbourne, Australia.

ORCID-Profile: Patrick Hilley, Darren Wong, Peter De Cruz

Förderung

  • NHMRC Emerging Leader 2 Fellowship

Zitieren

APA

Hilley, P., Wong, D., & De Cruz, P. (2025). How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae196

Vancouver

Hilley P, Wong D, De Cruz P. How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae196

BibTeX
@article{Hilley2025,
  author = {Hilley, Patrick and Wong, Darren and De Cruz, Peter},
  title = {How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izae196}
}
Kostenlos starten →